|
MSC-CRC interaction | Mode of function | Mechanisms | References |
|
Inhibition | Cell-to-cell contact | Inhibiting the expression of proinflammatory cytokines and STAT3 activation | [133] |
Cell-to-cell contact | Induces apoptosis and interferes with tumor initiation through the dysregulation of Wnt and TGF-β-Smad signaling pathways | [134] |
Paracrine | miR-165-p overexpression in BM-MSC-exosomes inhibited the proliferation, migration, and invasion and promoted apoptosis of CRC cells by downregulating ITGA2 expression. | [135] |
Paracrine | miR-4461 in BM-MSC-exosomes inhibits the proliferation, migration, and invasion of CRC cells by reducing the expression of COPB2. | [136] |
Paracrine | MSC-exosome-derived miR-3940-5p inhibited CRC cell invasion, EMT, and metastasis by targeting ITGA6 and subsequent TGF-β1 inactivation. | [137] |
Paracrine | miR-15a carried by AD-MSC-EVs restricted CRC immune escape by downregulating the KDM4b/HOXC4/PD-L1 axis. | [138] |
|
Promotion | Cell-to-cell contact | Regulating cell cycle and inhibiting apoptosis through the activation of NF-κB mediated by AMPK/mTOR | [143] |
Cell-to-cell contact | Promoting the progression of CRC cells through IL-6/JAK 2/STAT3 signal | [144] |
Cell-to-cell contact | The activation of JAK/STAT3 stimulated by the TGF-β1 or CXCR4/TGF-β1 axis can induce MSCs to differentiate into CAFs, which can promote the progression of CRC. | [66, 145, 152] |
Cell-to-cell contact | Interacting with CRC cells through CCL3/4/5 -CCR5 to promote the growth of CRC tumors in vivo | [148] |
Cell-to-cell contact | Promoting the EMT process of CRC through the CCL5/β-catenin/Slug pathway and SPARC | [147, 151] |
Cell-to-cell contact | Activating the HER2/HER3-dependent PI3K/Akt signaling cascade in CRC cells by releasing soluble NRG1. | [149] |
Cell-to-cell contact | Affecting the early xenograft growth of CRC cells with specific α-catenin deficiency by secreting extracellular matrix | [150] |
Cell-to-cell contact | Regulating the P53/P21 pathway through posttranscriptional regulation helps CRC resist senescence. | [153] |
Cell-to-cell contact | Promoting CRC angiogenesis through paracrine’s high levels of the proangiogenic factor IL-8 | [154] |
Paracrine | miR-222 targets ATF3 and inhibits the transcriptional activity of AKT1, thereby promoting malignant invasion and immune escape of CRC cells. | [157] |
|
Affection | Paracrine | Inducing morphological and functional changes in colon mesenchymal stem cells by secreting exosomes | [155] |
|